Cargando…

Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer

Outcomes for metastatic colorectal cancer (mCRC) patients have been improved by treatment with anti-epidermal growth factor receptor (anti-EGFR) antibodies, particularly when combined with predictive biomarkers to select patients lacking RAS mutations. New technologies such as liquid biopsy and next...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Yuji, Suyama, Koichi, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412337/ https://www.ncbi.nlm.nih.gov/pubmed/28368335 http://dx.doi.org/10.3390/ijms18040752

Ejemplares similares

Essential updates 2020/2021: Colorectal diseases (benign)—Current topics in the surgical and medical treatment of benign colorectal diseases
por: Sawayama, Hiroshi, et al.
Publicado: (2022)

Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options
por: Scartozzi, M, et al.
Publicado: (2007)

Current concepts of anti-EGFR targeting in metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2022)

Recent Advance in the Surgical Treatment of Metastatic Colorectal Cancer-An English Version
por: Park, Eun Jung, et al.
Publicado: (2022)

Emerging evidence of immunotherapy for colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2022)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
por: Matsuishi, Kozue, et al.
Publicado: (2020)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

Recent developments in the treatment of metastatic colorectal cancer
por: Loree, Jonathan M., et al.
Publicado: (2017)

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
por: Lee, Suk-young, et al.
Publicado: (2016)

The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
por: Horino, Taichi, et al.
Publicado: (2021)

Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019)

Recent advances in treatment of metastatic breast cancer
por: Coleman, R
Publicado: (2010)

Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
por: Soulières, D., et al.
Publicado: (2010)

An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
por: Rosati, Gerardo, et al.
Publicado: (2022)

Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020)

EGFR Signaling in Colorectal Carcinoma
por: Krasinskas, Alyssa M.
Publicado: (2011)

Efficacy of delayed primary closure with intrawound continuous negative pressure and irrigation treatment after surgery for colorectal perforation
por: Ogawa, Katsuhiro, et al.
Publicado: (2021)

Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment
por: Narbona, Javier, et al.
Publicado: (2023)

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition
por: Ottaiano, Alessandro, et al.
Publicado: (2013)

Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer
por: Sagawa, Tamotsu, et al.
Publicado: (2023)

Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022)

Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
por: Cann, Christopher G., et al.
Publicado: (2023)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
por: Mao, C, et al.
Publicado: (2010)

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
por: Riera, Pau, et al.
Publicado: (2020)

Molecular Targets for the Treatment of Metastatic Colorectal Cancer
por: Cohen, Romain, et al.
Publicado: (2020)

Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial
por: Oki, Eiji, et al.
Publicado: (2020)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Synchronous NET and colorectal cancer development: a case report
por: Yumoto, Shinsei, et al.
Publicado: (2020)

Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Cancer-related multiple brain infarctions caused by Trousseau syndrome in a patient with metastatic colon cancer: a case report
por: Akiyama, Takahiko, et al.
Publicado: (2016)

Advances of Wnt Signalling Pathway in Colorectal Cancer
por: Zhu, Yaoyao, et al.
Publicado: (2023)

Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma
por: Fostea, Raluca Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ml2ccq1bmdcl8h5kbmu88dd2m8